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Background: Family-based treatment is an efficacious outpatient intervention for medically stable adolescents with
anorexia nervosa. Previous research suggests family-based treatment may be more effective for some families when
parents and adolescents attend separate therapy sessions compared to conjoint sessions. Our service developed
a novel separated model of family-based treatment, parent-focused treatment, and is undertaking a randomised
controlled trial to compare parent-focused treatment to conjoint family-based treatment.
Methods/Design: This randomised controlled trial will recruit 100 adolescents aged 12–18 years with DSM-IV
anorexia nervosa or eating disorder not otherwise specified (anorexia nervosa type). The trial commenced in 2010
and is expected to be completed in 2015. Participants are recruited from the Royal Children’s Hospital Eating
Disorders Program, Melbourne, Australia. Following a multidisciplinary intake assessment, eligible families who
provide written informed consent are randomly allocated to either parent-focused treatment or conjoint family-based
treatment.
In parent-focused treatment, the adolescent sees a clinical nurse consultant and the parents see a trained mental health
clinician. In conjoint family-based treatment, the whole family attends sessions with the mental health
clinician. Both groups receive 18 treatment sessions over 6 months and regular medical monitoring by a paediatrician.
The primary outcome is remission at end of treatment and 6 and 12 month follow up, with remission defined as
being ≥ 95% expected body weight and having an eating disorder symptom score within one standard deviation
of community norms. The secondary outcomes include partial remission and changes in eating pathology,
depressive symptoms and self-esteem. Moderating and mediating factors will also be explored.
Discussion: This will be first randomised controlled trial of a parent-focused model of family-based treatment of
adolescent anorexia nervosa. If found to be efficacious, parent-focused treatment will offer an alternative approach
for clinicians who treat adolescents with anorexia nervosa.
Trial registration: Australian and New Zealand Clinical Trials Registry ACTRN12610000216011.
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Anorexia nervosa (AN) is an eating disorder charac-
terised by restricted dietary intake leading to low body
weight, a fear of weight gain, and disturbed body image
[1]. The highest incidence of AN is during adolescence
[2], with 1.1% of adolescents having a lifetime history of
AN or subthreshold AN (i.e., eating disorder not else-
where classified; DSM-IV EDNOS) [3]. AN has a signifi-
cantly detrimental impact on physical and psychological
functioning, including having the highest mortality rate
of all psychiatric conditions [2]. Current evidence sup-
ports family-based treatment (FBT) as an efficacious
outpatient intervention for medically stable adolescents
with AN [4-8]. Our research compares a parent-focused
model of FBT in which parents and adolescents attend
treatment sessions separately to a standard conjoint model.
FBT is a manualised outpatient treatment in which a
mental health clinician assists parents to actively support
weight gain and normalise eating patterns for their adoles-
cent [9]. Treatment initially focuses on weight restoration.
Parents are required to take control of meals, support
their adolescent to eat, and prevent compensatory beha-
viours. Once weight is restored and resistance lowered,
control of eating is returned to the adolescent and deve-
lopmental issues can be addressed. Traditionally, FBT is
delivered in a conjoint model whereby the whole family is
seen together by the therapist (hereafter referred to as
conjoint family-based treatment; CFT). While CFT allows
the therapist to directly observe and intervene in family
interactions, it also raises many challenges. For example,
the content of sessions may not be suitable for all family
members at all times, and some parents may be critical of
their adolescent or display distress which impacts nega-
tively on their adolescent [6,10,11]. The adolescent’s illness
may also manifest in behaviours which interfere with the
therapeutic process between the parents and therapist. In
addition, there are practical issues that may prevent family
members attending sessions together (e.g., work, school,
travel) or that impede therapists being able to accom-
modate whole families (e.g., small office space) [12].
The CFT model also poses a challenge for dissemin-
ation of FBT, in that therapists without formal training
in general family therapy are at times reluctant to treat
within a conjoint format that includes patient, parents,
other caregivers, and siblings. Of particular concern is
the second session of FBT, an in-vivo family meal in which
the therapist must facilitate parental efforts in the nutri-
tional rehabilitation of their ill child, while mobilising the
siblings to take on a supportive role. The success of this
powerful session is one hypothesised mechanism of FBT,
but no dismantling studies demonstrating its unique con-
tribution to treatment outcomes have been conducted.
Separated models of FBT in which the adolescent and
parents are seen in separate individual sessions canovercome many of the difficulties of CFT, may be just
as effective as CFT, and may even be better suited to
some families. In the earliest randomised controlled
trial of separated family therapy (SFT) [5], 18 adoles-
cents with AN received either CFT or a SFT model in
which the therapist spent part of the session with the
adolescent alone and part of the session with the par-
ents alone. Both groups had a significant increase in
weight, but although there was a somewhat greater in-
crease in the SFT group (+19.9% expected body weight,
EBW) compared to the CFT group (+13.2% EBW),
group differences were not significant. In a subsequent
larger trial, 40 adolescents with AN were randomised
to CFT or SFT [6]. Using Morgan-Russell outcome
criteria [13], 76% of the SFT group had good or inter-
mediate outcome at end of treatment compared to
47% of the CFT group, with outcomes improving fur-
ther at 5-years follow-up (SFT = 90% and CFT = 78%
good/intermediate outcome) [11]. Once again, how-
ever, the group differences were not statistically signifi-
cant. Of importance, in both trials there was evidence that
adolescents from critical families (i.e., those with high
expressed emotion) had poorer outcome in CFT than in
SFT [5,6,11].
While the sample size of these studies limits the in-
terpretation of their findings, they provide preliminary
indications that SFT produces similar, and potentially
superior, outcomes to CFT. They further suggest that,
at least for some families, SFT may be uniquely clinic-
ally indicated. For the current study, we amplified the
differences between CFT and SFT to develop a sepa-
rated model of treatment in which the therapist sees
only the parents in treatment sessions while a nurse
attends to the monitoring of the adolescent’s weight,
mental and medical status and plays a supportive role.
By extension, there is no family meal session in this
model. Unlike CFT and previous separated models of
FBT, in this treatment parents are for the most part
the exclusive participants in therapy, similar to other
parent training-based psychological interventions [14].
Hence, the therapy was named parent-focused treat-
ment (PFT). The structure of PFT is described in the
Methods section.
Aims and hypotheses
The aims of this study are to:
1. Examine the relative benefits of PFT compared to
CFT in a randomised controlled trial with a cohort
of outpatients with AN and EDNOS- Anorexia
Nervosa type (EDNOS-AN);
2. Explore predictors and moderators of treatment
response; and
3. Explore mediators of treatment response.
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1. PFT will be more effective than CFT as indicated by
more participants achieving full remission and
partial remission after 6 months of treatment and at
6 and 12 months follow-up;
2. Adolescents with parents who are highly critical and
are assigned to PFT will have better outcomes
compared to adolescents with parents who are
highly critical and are assigned to CFT;
3. Regardless of treatment assignment, outcomes will be
poorer for adolescents with co-morbid psychiatric
illness, high levels of obsessionality, features of
personality disturbance, parent psychopathology, high
levels of parental criticism, poor therapeutic
relationship, and/or low expectation for treatment
effectiveness. These factors will also be explored as
potential moderators of outcomes with respect to
treatment assignment;
4. Treatment response will be mediated by reduced dietary
restraint and depressive symptomatology, and increased
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Figure 1 Participant flowchart.Methods
Overall study design
The study is a randomised controlled trial (RCT) of two
active interventions: CFT and PFT. Each participant re-
ceives 6 months of treatment and is followed up to
12 months post-treatment completion. Participant flow
through the study is shown in Figure 1. Study recruitment
began in July 2010 and is estimated to continue until July
2014, with the final 12-month follow-up assessment due
to be completed in December 2015. The study is regis-
tered with the Australian and New Zealand Clinical Trials
Registry (ACTRN 12610000216011). Ethics approval has
been granted by the Royal Children’s Hospital Human Re-
search Ethics Committee (#30035).
Setting
The Royal Children’s Hospital Eating Disorder Program is a
multidisciplinary specialist program that provides inpatient
and outpatient medical management and outpatient
FBT for adolescents with AN (see [15] for a detailed
program description). The team includes clinicians
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their general practitioner or other provider. Following a
standardised phone triage conducted with the parents by
a clinical nurse consultant, the patient and their parents
attend a one-day multidisciplinary assessment clinic for
diagnostic evaluation, medical examination and treatment
planning. This assessment includes administration of stan-
dardised assessments by research staff not involved in
treatment delivery. Prior to attending the assessment clinic,
families are sent an information pack including written
questionnaires.
Patients are also referred for outpatient FBT by the Royal
Children’s Hospital adolescent inpatient unit. These pa-
tients and their parents undergo the same assessment while
an inpatient and commence treatment upon discharge.
Participants
Participants will be 100 families of adolescents aged be-
tween 12 and 18 years inclusive. Eligible participants are
identified during triage and intake assessment. Sample
size calculation for this study was based upon two con-
trolled trials of FBT [6,8]. It was calculated that for 80%
power and a two-tailed significance level of .05, it would
be possible to detect an 27% difference between CFT
and PFT (dichotomous outcome of remitted versus non-
remitted) with a sample size of 45 participants per group.
Assuming a dropout rate of 10%, the enrolled sample size
requires 50 participants per group.
Treatment groups will be compared on sociodemo-
graphic and clinical characteristics at baseline using
Fisher’s Exact test for dichotomous variables (e.g., gender,
family status), chi-square for categorical variables (e.g.,
ethnicity, comorbid diagnoses), and independent sample
t-tests for continuous measures (e.g., age, % EBW).
Inclusion criteria
Participants are eligible to participate if they are aged be-
tween 12 to 18 years, meet DSM-IV criteria for AN (ex-
cluding the amenorrhea criterion) or EDNOS-AN [16],
are sufficiently medically stable for outpatient treatment,
and are living with at least one parent or guardian who
can read and speak English to at least a sixth-grade level.
DSM-IV criteria were applied as the trial commenced
prior to publication of the DSM-5 [1]. In anticipation of
the DSM-5 criteria, however, the amenorrhea criterion
was excluded and, in the absence of explicit acknow-
ledgement of fear of weight gain or becoming fat, per-
sistent behaviours that interfere with weight gain are
considered diagnostic. Weight thresholds are ≤85% EBW
for AN and 85-90% EBW for EDNOS-AN. For adoles-
cents at or above the 75th percentile for height, the weight
threshold was set higher (≤95% EBW). EBW is calculated
from median body mass index for age and gender using
the Centers for Disease Control charts [17]. Medicalstability is determined by a paediatrician or nurse accord-
ing to a standard protocol that was informed by published
guidelines [18].
Exclusion criteria
Participants are excluded from entry into the study if
they present with current psychotic disorder, depend-
ence on drugs or alcohol, explicit suicidal risk (i.e., re-
quiring hospitalisation or high level supervision), or a
physical condition known to influence eating or weight
(e.g., pregnancy, cancer). Participants who have previ-
ously received 10 or more FBT sessions with a trained
FBT clinician are also excluded. Participants on psycho-
tropic medication who meet inclusion criteria for the
study are only eligible for participation if they have been
on a stable dose of for a period of at least 8 weeks and the
medication has not been prescribed for the primary pur-
pose of weight gain. In the case of patients with current or
a history of recent or past physical or sexual abuse by a
family member, the perpetrator of the abuse is excluded
from treatment. If physical or sexual abuse by a family
member occurs in the course of treatment, the perpetrator
is excluded from ongoing treatment and appropriate pro-
tective services are notified if indicated by Victorian laws.
Recruitment
Information statements about the RCT are included in
the information pack posted to each family prior to at-
tending the assessment clinic. Following completion of
the intake assessment and feedback regarding diagnosis,
a researcher explains the treatment to the parents and pa-
tient and, if eligible, informs them of the RCT and invites
them to participate. If the family agrees, the adolescent and
parents sign written consent forms. Consent includes a
choice of whether to have assessment and treatment ses-
sions audio recorded and whether to allow data to be used
for other future ethically-approved research.
Randomisation
A statistician independent of the research group gener-
ated a randomisation schedule using block randomisa-
tion with variable block sizes (currently masked from
research personnel). Randomisation is stratified by eat-
ing disorder severity (low vs. high) to ensure equal allo-
cation to each of the treatment arms. High severity is
defined as <80% EBW, illness duration >12 months, and
the presence of one other psychiatric diagnosis (i.e., all
three criteria must be met). The randomisation schedule
is only accessible by designated staff members at the
Royal Children’s Hospital who are independent of the Eat-
ing Disorders Program team including the research team.
When randomisation is required, a researcher sends an
email with the participant identification number and se-
verity category to one of the independent staff members
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email and the researcher communicates the allocation to
the family and treating clinicians.
Interventions
All participants, regardless of treatment group, receive
18 therapy sessions over 6 months. The frequency of
sessions is the same across treatment groups: twice
weekly in weeks 1 and 2, weekly for weeks 3 to 10, fort-
nightly for weeks 11 through 18, and every third week
for weeks 19 to 24. In other words, dose and intensity of
treatment are the same for CFT and PFT.
Conjoint Family-Based Treatment (CFT). In CFT, the
whole family is expected to attend treatment sessions.
This includes the adolescent, both parents (for two-parent
families), and siblings. Treatment progresses through
three phases detailed in the treatment manual [9]. In the
first phase (sessions 1–12), therapy is focused on the eat-
ing disorder and includes a family meal undertaken in ses-
sion two. This phase is characterised by attempts to
absolve the parents from the responsibility of causing the
disorder, and by capitalising on the strengths of their par-
enting to facilitate their offspring’s nutritional rehabili-
tation. Families are encouraged to work out for themselves
how best to restore their child’s weight, drawing on a com-
bination of common-sense practices (i.e., FBT asks par-
ents, “What would you be feeding your child now if s/
he were underweight for a medical reason?” and cau-
tions them against symptom accommodation) and the
eating disorders expertise of the therapist. In Phase 1,
the majority of weight restoration is accomplished. In
Phase 2 (sessions 13–16), once weight restoration is
nearing completion, parents are helped to transition
eating and weight control back to the adolescent in a
developmentally appropriate manner. The third phase
(sessions 17–18) is initiated when the patient achieves a
stable weight and self-starvation has abated. The central
theme is the establishment of a healthy adolescent stage of
development in all aspects of functioning, including the
patient’s relationship with his or her parents. In CFT, the
mental health clinician weighs the patient at the beginning
of each session and spends approximately 10 minutes with
the adolescent before bringing the rest of the family in for
the remainder of the 50-minute session.
Parent-Focused Treatment (PFT). In PFT, treatment
progresses through the same three phases as CFT [9],
however the parents and adolescent are seen in separate
sessions. Each appointment begins with the adolescent
being seen by the clinical nurse consultant who weighs
the adolescent, assesses medical stability as needed, and
provides brief supportive counselling for up to 15 mi-
nutes. The nurse communicates the weight and any
other pertinent information to the therapist who then
sees the parents for 50 minutes. The focus and contentof the parent sessions are the same as in CFT, but without
direct interaction with the adolescent. The only direct
contact between the therapist and adolescent is at the first
session, when the therapist briefly introduces themselves,
and at the end of the final session, when the therapist fare-
wells the family. As noted above, there is no family meal
in PFT. Siblings are not included in PFT treatment ses-
sions but other caregivers involved in weight restoration
can be included (e.g., grandparent). A study treatment
manual was developed for PFT and a detailed description
of PFT will soon be published [19].
Treatment fidelity
Therapists participate in weekly clinical supervision ei-
ther in-person or via teleconference with an expert FBT
clinician (authors DLG and KLL) to review treatment
progress and ensure adherence to the treatment proto-
col. All treatment sessions for which consent has been
provided are audio recorded. Randomly selected record-
ings are reviewed by author DLG throughout the trial.
Additional patient monitoring
Medical oversight is provided at an outpatient appoint-
ment with a paediatrician at a minimum of every five
weeks. The decision to hospitalise patients is made by the
paediatrician and clinical team according to the team’s eat-
ing disorders admission protocol. If a participant requires
hospitalisation for ≤ 21 days during the treatment phase of
the study, they return to their allocated therapeutic arm
after discharge and complete the treatment course. Admis-
sions to hospital longer than 21 consecutive days or a third
admission during treatment results in exclusion from the
study treatment phase. Such participants are offered con-
tinued treatment as recommended by the clinical team.
Referrals can be made to the team psychiatrist for as-
sessment of mental status and management of co-morbid
mental health conditions and psychiatric crises as re-
quired. Once treatment has commenced, psychotropic
medication can be prescribed by the psychiatrist for co-
morbid conditions (e.g., depression, anxiety). If the condi-
tion is not pre-existing, the EDE [20] is administered prior
to commencement of medication.
Measures
The study assessment timeline is shown in Table 1. The
assessments are part of routine care of all patients in FBT
at the service. Face-to-face assessments are conducted at
baseline, week 4, week 12, end of treatment (i.e., Week
24), and at 6 and 12 months post-treatment completion.
Written questionnaires are completed at each of these
face-to-face assessments and at fortnightly intervals dur-
ing the first 12 weeks of treatment. As a token of appre-
ciation and reimbursement for time and travel, parents
and adolescents receive a $20 gift card for attending each
Table 1 Study measures and time points
Measure Source Baseline Each treatment
session
Week 1 Week 2 Week 4 Weeks 6,
8 & 10




Weight Adolescent ✓ ✓ ✓ ✓ ✓ ✓
Height Adolescent ✓ ✓ ✓ ✓
Menstrual status Adolescent ✓ ✓ ✓ ✓ ✓
Binge/purge frequency Adolescent ✓ ✓ ✓ ✓ ✓ ✓
Eating Disorder Examination Adolescent ✓ ✓ ✓ ✓
Parent ✓ ✓ ✓ ✓
Mini International
Neuropsychiatric Interview
Adolescent ✓ ✓ ✓
Parent ✓ ✓ ✓
Children’s Yale-Brown
Obsessive Compulsive Scale
Adolescent ✓ ✓ ✓ ✓ ✓
Yale-Brown-Cornell Eating
Disorder Scale
Adolescent ✓ ✓ ✓ ✓ ✓
Five Minute Speech Sample Parent ✓ ✓ ✓ ✓ ✓
Symptom Checklist-90-R Parent ✓
Family Environment Scale Adolescent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Parent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Borderline Personality
Questionnaire
Adolescent ✓ ✓ ✓ ✓
Children’s Depression
Inventory
Adolescent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Rosenberg Self-Esteem Scale Adolescent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Eating Disorders
Examination-Questionnaire
Adolescent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Positive and Negative
Affect Scale
Adolescent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Parent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Parents Versus Anorexia Scale Parent ✓ ✓ ✓ ✓ ✓ ✓ ✓
Therapy Suitability and
Patient Expectancy
Adolescent ✓ ✓ ✓ ✓ ✓ ✓
Parent ✓ ✓ ✓ ✓ ✓ ✓
Helping Relationship
Questionnaire
Adolescent ✓ ✓ ✓ ✓ ✓
Parent ✓ ✓ ✓ ✓ ✓
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follow-up. Participants who complete all written question-
naires are entered into a yearly draw for a $100 gift card.
Eating Disorder Examination (EDE) [21]. The EDE is a
semi-structured interview used to diagnose eating disor-
ders. It measures eating-related attitudes, cognitions, and
behaviours primarily during the past 28 days. The EDE
yields four subscale scores (Restraint, Eating Concern,
Weight Concern, and Shape Concern) and a global score
measuring the overall severity of eating disorder psycho-
pathology. Behavioural symptoms of eating disorders (e.g.,
binge eating, purging) are assessed through a series of
diagnostic questions about the frequency of behaviours in
the 3–6 months prior to assessment. The EDE has good
reliability and validity [22] and has been used in several
studies of paediatric eating disorders [8,23].A parent-report version (PEDE) is also utilised in this
study [24,25]. Findings from the EDE and PEDE are in-
tegrated with the psychiatrist’s assessment to arrive at
the diagnosis at baseline.
Expected Body Weight (% EBW). This is calculated as
[current BMI]/[50th percentile BMI] × 100. The 50th per-
centile BMI is determined using the Centers for Disease
Control charts relative to gender and age to the closest
6 months [17]. Weight is measured to the nearest 0.05 kg
using regularly calibrated digital scales. A trained re-
searcher weighs the adolescent in a gown, and the
therapist/nurse weighs the adolescent in light indoor
clothing without shoes. Height is measured to the nearest
0.1 cm using a wall mounted stadiometer. A trained re-
searcher measures the adolescent’s height without shoes
using a standard protocol.
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sodes in the previous week are assessed by self-report at
each treatment session and each assessment time point.
Mini International Neuropsychiatric Interview for Chil-
dren and Adolescents (MINI-Kid) [26]. The MINI-Kid is
a structured clinical interview for assessment of DSM-IV
psychiatric disorders in children and adolescents. The
MINI-Kid has been shown to be a reliable and valid as-
sessment of psychiatric disorders [27,28]. The results of
the MINI-Kid self-report and parent-report versions are
integrated with the psychiatrist’s assessment to arrive at
a final diagnosis at baseline.
Children’s Yale-Brown Obsessive Compulsive Scale (CY-
BOCS) [29]. The CY-BOCS is a semi-structured interview
designed to assess the presence and severity of obsessions
and compulsions in children. The CY-BOCS was modified
for children from the adult Yale-Brown Obsessive Com-
pulsive Scale (Y-BOCS) [30]. The CY-BOCS has been
shown to have high internal consistency as well as good
convergent and divergent validity [29].
Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS)
[31]. Based on the Y-BOCS, the YBC-EDS is designed to
assess the presence and severity of obsessions and com-
pulsions related to eating behaviours, weight, and exercise.
Studies of patients with eating disorders have demon-
strated the YBC-EDS has good reliability and validity, and
is sensitive to change over the course of therapy [31,32].
Five Minute Speech Sample (FMSS) [33]. The FMSS
was developed as a brief measure of expressed emotion
in family members of individuals with a psychiatric ill-
ness. The parent is asked to speak for 5 minutes about
their child and the content is coded by trained assessors.
Content is rated as either high or low in expressed emotion
based on level of criticism and emotional over-involvement
displayed during the speech sample. In studies of relatives
of individuals with schizophrenia [33,34] and individuals
with AN [35], the FMSS has been shown to be comparable
to the Camberwell Family Interview [36], a 1–2 hour long
semi-structured interview considered the gold standard for
assessing expressed emotion.
Symptom Checklist-90-R (SCL-90-R) [37]. The SCL-
90-R is a 90-item self-report measure of psychiatric
symptomatology including depression, anxiety, obsessive-
compulsive, and psychotic symptoms. The respondent
indicates the degree to which they have been distressed
by each symptom during the preceding week. Studies
have shown the SCL-90-R to have good internal
consistency and to be a valid measure of general psy-
chiatric distress [38,39].
Family Environment Scale (FES) [40]. The 27-item rela-
tionship dimension of the FES is used to assess the degree
of cohesion, expressiveness, and conflict in the family.
This scale has been used in numerous studies to assess
family functioning including studies of eating disordersymptomatology [41]. The FES has been shown to have
good internal consistency, to correlate with other mea-
sures of family environment, and to change with family-
focused interventions [40].
Borderline Personality Questionnaire (BPQ) [42]. The
BPQ is an 80 item, self-report measure of borderline
personality traits as defined by the DSM-IV (e.g.
affective instability, impulsivity, self-harm, fear of aban-
donment, relationship difficulties, and identity issues).
This questionnaire has been shown to have good in-
ternal consistency and validity [42,43]. In a sample of
Australian adolescents, the BPQ was found to have high
internal consistency, diagnostic accuracy, high test-retest
reliability, and moderate sensitivity [44].
Children’s Depression Inventory (CDI) [45]. The CDI is
a 27-item self-report measure of depressive symptom-
atology experienced by children and adolescents in the
past 2 weeks. Studies have shown the CDI to have high
internal consistency and to be a valid measure of overall
level of depressive symptomatology in children and ado-
lescents [46,47]. The suicidal ideation item is not in-
cluded in this study.
Rosenberg Self-Esteem Scale (RSE) [48]. The RSE is a
widely used self-report instrument of 10 items measur-
ing an individual’s overall self-esteem. A meta-analysis of
23 factor analytic studies including 32,491 participants
found support for a one-factor model of self-esteem as
measured by the RSE [49].
Eating Disorders Examination-Questionnaire (EDE-Q)
[50]. The EDE-Q is a self-report measure adapted from
the EDE. Only the 5-item Dietary Restraint subscale is
used in this study to assess attempts to restrict dietary
intake. The EDE-Q Restraint Scale has high internal
consistency [51] and results are highly comparable to
those assessed using the EDE interview [52].
Positive and Negative Affect Scale (PANAS) [53,54]. The
PANAS is a self-report measure of positive and negative
affect. The respondent is presented with a list of feelings
(e.g., sad, happy, irritable) and ask to indicate to what ex-
tent they felt that way in the past 2 weeks. It is a well vali-
dated, reliable and widely used measure of emotional
experience for use with both adults and children [53,54].
The current study utilises 41 items from the PANAS Ex-
panded Form [53] to derive Positive Affect and Negative
Affect scales as well as the Fear, Hostility, Guilt, Sadness
and Joviality subscales. Adolescents report on their own
emotional experience and parents report on their observa-
tions of their child’s emotional expression.
Parents Versus Anorexia Scale (PVA) [55]. This is a 7-
item measure of self-efficacy of parents in FBT; that is,
parents’ perceptions of their ability to bring about recov-
ery in their child [55]. The measure was designed to
align with the principles of FBT outlined in the manual
[9]. The PVA has been found to have acceptable internal
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crease in % EBW during FBT [55].
Therapy Suitability and Patient Expectancy [56].
Parent and adolescent perception of the suitability of
the treatment is assessed with the question “How suit-
able do you think this therapy is for your problem?”
Their expectation of improvement with treatment is
assessed with the question “How successful do you
think therapy will be?” Each item is rated on an 11-
point scale (0 =Not at all, 10 = Extremely). The ques-
tions were adapted from those used in a trial of FBT
for bulimia nervosa [56].
Helping Relationship Questionnaire (HRQ) [57]. The
HRQ measures two main aspects of the therapeutic rela-
tionship: the experience of being helped and supported,
and the experience of being in a collaborative effort with
the therapist. Eleven items are rated on a 6-point scale
(−3 = Strongly feel it’s true, +3 Strongly feels it’s untrue).
Two additional open-ended questions ask the respond-
ent to comment on the ways they feel improved and the
ways they feel worse, and a final item asks the respond-
ent to rate their improvement so far (1 =Not at all, 5 =
Very much). The HRQ has been used in a trial of FBT
for bulimia nervosa [56].
Primary outcome
The primary outcome is full remission, defined as ≥ 95%
EBW and an EDE Global score within one standard de-
viation of community norms.
Secondary outcomes
The secondary outcomes are partial remission (defined as ≥
85% EBW) and changes in eating pathology (EDE subscales
and behaviour frequency scores), depressive symptoms
(CDI) and self-esteem (RSE).
Data analysis
Remission will be determined separately at post-treatment
and follow-up. The primary outcome analysis will be based
upon intent-to-treat. In those cases in which there are
missing post-treatment or follow-up data, the pre-
treatment observation will be carried forward to charac-
terise that participant’s response [58]. Groups will be
compared on remission at post-treatment and follow-up
using two-tailed Fisher’s Exact test with alpha set to .05.
The secondary outcome category is the proportion of
participants partially remitted. CFT and PFT will be
compared at post-treatment and follow-up using Fish-
er’s Exact test.
A secondary analysis will be performed using a mixed
effects linear regression model [59] to compare CFT and
PFT participants on eating pathology, depression and self-
esteem at mid-treatment (week 12), end-of-treatment
(week 24), 6-month follow-up, and 12-month follow-upcontrolling for pre-treatment levels. Analyses will be
performed on log-transformed variables for behavioural
frequencies to satisfy the assumptions for the linear
model. Random regression models allow for the inclu-
sion of individuals with missing data. Consequently, no
data imputation will be performed. Comparisons be-
tween groups will be based upon the main effect for
group with a two-tailed alpha of .05. Post hoc compari-
sons between groups at specific time-points will be
based upon a two-tailed Bonferroni corrected Post hoc
comparisons between groups at specific time-points will
be based upon a two-tailed Bonferroni corrected alpha
of .0125 (.05/4).
Moderation analyses will be performed using logistic
regression analyses, with models using main effects for
treatment, moderator, and treatment-by-moderator ana-
lyses to predict remission at post-treatment and follow-
up assessments. Bootstrap mediation analyses with bias-
corrected confidence intervals will be performed using
the PROCESS macro developed by Hayes [60].
Discussion
This trial will be the largest randomised trial of a sepa-
rated model of FBT for adolescents with AN to date. If
found to be efficacious, PFT has the potential to increase
recovery rates by offering clinicians and families an alter-
native approach to standard conjoint FBT.
Although standard FBT has the most promising
evidence-base for treatment of adolescent AN [61,62],
it has significant limitations. As described earlier, the
standard conjoint format described in the manual (i.e.,
CFT) [9] raises many challenges and is difficult for
many families and therapists to adhere to for a variety
of reasons [12,19]. Moreover, studies using strict out-
come criteria suggest CFT only achieves remission in
around 50% of adolescents [6,8]. As individual therap-
ies are generally found to be less effective in this popu-
lation [8,63], clinicians and researchers tend to focus
on improving outcomes by modifying FBT. This trial
builds on two previous studies that indicated restructuring
FBT with parents and adolescents attending separate ses-
sions may be an efficacious alternative treatment for some
families.
Of importance, the trial will not only indicate whether
PFT is a more efficacious alternative to CFT, but
moderator analyses will indicate whether there are
specific patient or family characteristic that are useful
in guiding the selection of treatment approach. For ex-
ample, previous research suggests highly critical families
may be better suited to SFT rather than CFT [5,6] and that
adolescents with high eating-related obessionality are bet-
ter suited to CFT than adolescent-focused therapy [64].
Furthermore, mediation analyses in this trial will indicate
potential mechanisms of action which could be the
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remission is shown to be mediated by improved parent
efficacy, techniques could be integrated into FBT to in-
crease efficacy in parents who struggle with this during
treatment.
So far the study has progressed smoothly and is ex-
pected to conclude in December 2015 as scheduled. Re-
cruitment rates have been somewhat uneven, being
higher than expected initially and in recent months,
and lower between times. Periods of slowed recruitment
have been largely attributable to families who present to
the program being ineligible for the trial. Of note, 33%
(70/214) of adolescents assessed between July 2010 and
January 2014 were above the % EBW cut-off for the
trial. Most of these were diagnosed with EDNOS-AN
type, with just nineteen excluded for reasons other than
weight (e.g., age, language, diagnosis). Our program has
noted a rise in this type of presentation [65]. Defined in
the DSM-5 as atypical anorexia nervosa, these adoles-
cents have all the features of AN but despite significant
weight loss are not underweight [1]. This appears to be
an important emerging population that will require fu-
ture research investment.
In conclusion, this trial will address an important
clinical need by testing a modified model of FBT for
adolescent AN in one of the largest randomised trial
of its kind. AN is a life-threatening psychiatric illness
which has a profound impact on an adolescent’s phys-
ical, psychological and social functioning [2]. The de-
velopment of treatments that are effective, acceptable
and achieve rapid remission during this critical de-
velopmental period is crucial. The trial with also pro-
vide an indication of factors which moderate and
mediate treatment outcome, the results of which will
be important to both the dissemination of PFT and for
further refinement of this treatment and other forms
of FBT.
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